Skip to content

E4 Pharmaceutical Consulting

E4 Biotechnology and Pharmaceutical Consulting. Providing product development (CMC), regulatory, QA/QC and project management support to companies developing new small-molecule drugs, biologics and medical devices.

Welcome!!

Categories

  • Regulatory (2)
    • Regulatory Strategy (1)
    • Regulatory Submissions (2)

E4 Pharmaceutical Consulting

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

RSS FDA News

RSS Pharma Times

  • Cellenkos presents promising phase 1b data for CK0804 in myelofibrosis
    New cell therapy shows potential in treating advanced blood disorder
  • CatalYm shows potential of visugromab for treating cachexia
    New findings presented at international SCWD conference
  • Imfinzi receives NICE recommendation for lung cancer treatment
    Trial results lead to new treatment option for lung cancer
  • Poolbeg Pharma presents positive results for POLB 001
    promising pre-clinical data on preventing cytokine release syndrome
  • Teva’s Ajovy shows positive results in preventing pediatric migraines
    Phase 3 trial indicates significant efficacy and safety for children and adolescents
  • NICE endorses Neuraxpharm’s ublituximab for treating MS
    New antibody therapy shows promise in managing condition
Proudly powered by WordPress / Theme: Shoreditch by Automattic.